New muscle therapy gets fast-track boost
Berlin start-up could soon be helping children with previously incurable muscle diseases thanks to an accelerated approval process
01-Aug-2023 -
To help bring therapies for rare muscle diseases in children to market sooner, the Berlin-based start-up MyoPax, a spin-off from the Max Delbrück Center and Charité – Universitätsmedizin Berlin, has now received a boost from the U.S. Food and Drug Administration (FDA). The company has been ...
clinical trials
muscle distrophy
muscles
+1